http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6730673-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
filingDate 2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17090e6f59957f872448aaae172e7a3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b023b7544069a4d735a054730d0671d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_363c15fe5178d6cfbf839815c0dde059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff84c2fd51ff2c61635a0c2b96da749b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9647957104688f813322128f09f18fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea4c517c08f5e1a16f849d43df1171d5
publicationDate 2004-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6730673-B1
titleOfInvention Pharmaceutical solutions of levosimendan
abstract Levosimendan solutions for pharmaceutical use, and particularly for intravenous administration. The solutions of the invention have enhanced stability and they are particularly useful as infusion or injection solutions or infusion concentrates. Levosimendan is useful in the treatment of congestive heart failure.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7279479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012093404-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007010518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6943164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004106617-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004092523-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006087420-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006087420-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607412-B2
priorityDate 1999-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9801111-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0565546-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9321921-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5512571-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5569657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6180789-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9735841-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5512572-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5424428-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87874838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226459474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127448226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231477300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230680381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230680373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247375059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15045640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129232388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91343987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57089479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10989605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142317506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135922523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14871

Total number of triples: 79.